Products 127253-06-9

CAS 127253-06-9 appears in our catalog under these names: Clarithromycin E-9-Oxime, >95% (HPLC), Clarithromycin Impurity 3（Clarithromycin EP Impurity C）, Clarithromycin EP Impurity C, Clarithromycin 9-Oxime (E/Z mixture), >95% (HPLC), Clarithromycin oxime. Offered by: TRC, Hubei YoungXin, Chemat Brand, Biosynth, MedChemExpress. Available pack sizes: 10mg, 25mg, 5mg, 50mg, 100mg, 200mg, on request, 2mg.

Clarithromycin E-9-Oxime, >95% (HPLC)
TRC
  • size: 10mg, 25mg, 5mg
  • Variants: 3
View product
Clarithromycin Impurity 3（Clarithromycin EP Impurity C）
Hubei YoungXin
  • size: 10mg, 25mg, 50mg, 100mg
  • Variants: 5
View product
Clarithromycin EP Impurity C
Chemat Brand
  • size: on request
  • Variants: 1
View product
Clarithromycin 9-Oxime (E/Z mixture), >95% (HPLC)
TRC
  • size: 10mg
  • Variants: 1
View product
Clarithromycin oxime
Biosynth
  • size: 2mg, 1mg, 5mg
  • Variants: 3
View product
Clarithromycin impurity 3
MedChemExpress
  • size: Get quote
  • Variants: 1
View product
Structural formula: {0} (CAS {1})

Clarithromycin related compound C is an aminoglycoside.

Source: ChEBI

Identity
Molecular formulaC38H70N2O13
Molecular weight763.0 g/mol
IUPAC name6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-10-hydroxyimino-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
InChIKeyMWBJRTBANFUBOX-UHFFFAOYSA-N
SMILESCCC1C(C(C(C(=NO)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O

Computed by PubChem (NCBI)

Synonyms: Clarithromycin Impurity L, Clarithromycin oxime, Clarithromycin EP impurity L, Clarithromycin EP impurity C
Related forms of this compound
6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-10-hydroxyimino-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one C38H70N2O13
(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-10-hydroxyimino-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one C38H70N2O13
Isomers (same molecular formula)
(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-methoxyimino-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one C38H70N2O13
N-[(2S,3R,4S,6R)-2-[[(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-1-oxa-6-azacyclopentadec-11-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylformamide C38H70N2O13
(1R,4R,4'R,5S,5'S,6R,6'S,7R,10R,12R,13R,14S,15S,17S)-13-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-4-ethyl-5,5',6,12-tetrahydroxy-4'-methoxy-4',5,6',7,8,10,12,14-octamethylspiro[3,16,18-trioxa-8-azabicyclo[13.4.0]nonadecane-17,2'-oxane]-2-one C38H70N2O13